Canopy Growth Corp (TSE:WEED – Get Free Report) shares reached a new 52-week low during trading on Thursday. The stock traded as low as C$1.17 and last traded at C$1.19, with a volume of 746527 shares changing hands. The stock had previously closed at C$1.26.
Analysts Set New Price Targets
Separately, Alliance Global Partners reduced their price objective on Canopy Growth from C$1.80 to C$1.60 in a report on Tuesday, June 16th. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of C$1.88.
Read Our Latest Report on WEED
Canopy Growth Stock Down 6.3%
Canopy Growth (TSE:WEED – Get Free Report) last announced its quarterly earnings data on Friday, August 7th. The company reported C($0.03) EPS for the quarter. Canopy Growth had a negative return on equity of 29.85% and a negative net margin of 73.95%.The company had revenue of C$81.17 million for the quarter. On average, research analysts forecast that Canopy Growth Corp will post -0.69 earnings per share for the current fiscal year.
Insider Activity at Canopy Growth
In other news, Director David Angelo Lazzarato sold 22,380 shares of the company’s stock in a transaction dated Monday, September 28th. The stock was sold at an average price of C$1.29, for a total value of C$28,870.20. Following the completion of the sale, the director directly owned 108,237 shares of the company’s stock, valued at C$139,625.73. This represents a 17.13% decrease in their position. Over the last three months, insiders sold 43,492 shares of company stock valued at $56,105. Corporate insiders own 0.21% of the company’s stock.
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands.
Further Reading
- Five stocks we like better than Canopy Growth
- PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value
- Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
- This Space ETF Offers SpaceX Exposure—But Investors Are Paying for the Volatilit
- Does Lemonade’s Growth Signal Profits Ahead?
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.
